Healthcare provider profile · identity verified

Scott M. Graham, DO

Family Practice · BREWSTER, MA · NPI 1154431609

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	838	196
Lisinopril	Lisinopril	680	138
Omeprazole	Omeprazole	421	117
Levothyroxine Sodium	Levothyroxine Sodium	409	84
Amlodipine Besylate	Amlodipine Besylate	399	102
Eliquis	Apixaban	394	41
Gabapentin	Gabapentin	350	48
Escitalopram Oxalate	Escitalopram Oxalate	288	62
Rosuvastatin Calcium	Rosuvastatin Calcium	274	66
Metoprolol Succinate	Metoprolol Succinate	265	50
Simvastatin	Simvastatin	239	47
Trazodone Hcl	Trazodone Hcl	239	45
Lorazepam	Lorazepam	185	45
Pantoprazole Sodium	Pantoprazole Sodium	177	45
Sertraline Hcl	Sertraline Hcl	174	28
Losartan Potassium	Losartan Potassium	157	42
Olmesartan Medoxomil	Olmesartan Medoxomil	148	43
Alendronate Sodium	Alendronate Sodium	141	50
Furosemide	Furosemide	137	29
Tamsulosin Hcl	Tamsulosin Hcl	137	44
Prednisone	Prednisone	135	70
Famotidine	Famotidine	132	14
Metformin Hcl	Metformin Hcl	123	38
Allopurinol	Allopurinol	118	33
Fluticasone Propionate	Fluticasone Propionate	115	48
Atenolol	Atenolol	114	20
Warfarin Sodium	Warfarin Sodium	109	suppressed
Celecoxib	Celecoxib	108	18
Tramadol Hcl	Tramadol Hcl	107	30
Citalopram Hbr	Citalopram Hydrobromide	106	28
Hydrochlorothiazide	Hydrochlorothiazide	97	26
Albuterol Sulfate Hfa	Albuterol Sulfate	90	40
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	85	suppressed
Meloxicam	Meloxicam	85	32
Pravastatin Sodium	Pravastatin Sodium	84	suppressed
Buspirone Hcl	Buspirone Hcl	80	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	78	suppressed
Alprazolam	Alprazolam	77	19
Donepezil Hcl	Donepezil Hcl	75	12
Potassium Chloride	Potassium Chloride	73	suppressed
Bupropion Xl	Bupropion Hcl	72	16
Valsartan	Valsartan	69	11
Xarelto	Rivaroxaban	69	13
Oxycodone Hcl	Oxycodone Hcl	68	19
Spironolactone	Spironolactone	67	suppressed
Mirtazapine	Mirtazapine	66	18
Carvedilol	Carvedilol	64	19
Metoprolol Tartrate	Metoprolol Tartrate	64	18
Glipizide Er	Glipizide	61	17
Memantine Hcl	Memantine Hcl	60	suppressed
Ozempic	Semaglutide	60	suppressed
Ipratropium Bromide	Ipratropium Bromide	55	23
Zolpidem Tartrate	Zolpidem Tartrate	53	19
Synthroid	Levothyroxine Sodium	52	13
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	50	suppressed
Januvia	Sitagliptin Phosphate	50	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	46	14
Amoxicillin	Amoxicillin	42	36
Myrbetriq	Mirabegron	42	suppressed
Levetiracetam	Levetiracetam	41	suppressed
Finasteride	Finasteride	38	12
Glipizide	Glipizide	38	suppressed
Clopidogrel	Clopidogrel Bisulfate	36	12
Duloxetine Hcl	Duloxetine Hcl	35	11
Jardiance	Empagliflozin	35	suppressed
Tizanidine Hcl	Tizanidine Hcl	35	19
Doxycycline Hyclate	Doxycycline Hyclate	33	25
Breo Ellipta	Fluticasone/Vilanterol	32	suppressed
Clonazepam	Clonazepam	30	suppressed
Montelukast Sodium	Montelukast Sodium	30	suppressed
Testosterone	Testosterone	30	suppressed
Azelastine Hcl	Azelastine Hcl	29	13
Triamcinolone Acetonide	Triamcinolone Acetonide	29	17
Wixela Inhub	Fluticasone Propion/Salmeterol	28	suppressed
Cephalexin	Cephalexin	27	22
Ropinirole Hcl	Ropinirole Hcl	27	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	26	23
Hydrocortisone	Hydrocortisone	26	12
Alfuzosin Hcl Er	Alfuzosin Hcl	25	suppressed
Diazepam	Diazepam	25	suppressed
Pregabalin	Pregabalin	25	suppressed
Ibuprofen	Ibuprofen	24	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	24	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	23	suppressed
Metformin Hcl Er	Metformin Hcl	23	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	23	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	22	suppressed
Ondansetron Hcl	Ondansetron Hcl	22	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	22	suppressed
Azithromycin	Azithromycin	21	20
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	20	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	20	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	19	suppressed
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	19	suppressed
Ezetimibe	Ezetimibe	19	suppressed
Chlorthalidone	Chlorthalidone	18	suppressed
Estradiol	Estradiol	18	suppressed
Creon	Lipase/Protease/Amylase	17	suppressed
Diclofenac Sodium	Diclofenac Sodium	17	13
Loperamide	Loperamide Hcl	17	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	17	17
Torsemide	Torsemide	17	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	16	suppressed
Buprenorphine	Buprenorphine	16	suppressed
Lansoprazole	Lansoprazole	16	suppressed
Nystatin	Nystatin	16	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	15	11
Phenobarbital	Phenobarbital	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Fenofibrate	Fenofibrate	14	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	14	suppressed
Primidone	Primidone	14	suppressed
Temazepam	Temazepam	14	suppressed
Butrans	Buprenorphine	13	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	13	suppressed
Morphine Sulfate Er	Morphine Sulfate	13	suppressed
Erythromycin	Erythromycin Base	12	12
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Glyxambi	Empagliflozin/Linagliptin	12	suppressed
Incruse Ellipta	Umeclidinium Bromide	12	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	12	suppressed
Olmesartan-Amlodipine-Hctz	Olmesartan/Amlodipin/Hcthiazid	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Trulicity	Dulaglutide	12	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	11	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	11	suppressed
Testosterone Cypionate	Testosterone Cypionate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error